Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec 22.
doi: 10.1007/s10266-025-01286-z. Online ahead of print.

miR-135b-5p modulates the progression and clinical outcomes of oral squamous cell carcinoma through the negative regulation of TXNIP

Ya Gao #  1   2 , Yi Lu #  3 , Kun Cao  4
Affiliations

miR-135b-5p modulates the progression and clinical outcomes of oral squamous cell carcinoma through the negative regulation of TXNIP

Ya Gao et al. Odontology. .

Abstract

Background Oral squamous cell carcinoma (OSCC) is a common malignant tumor of the oral cavity with a poor prognosis. Purpose This study aimed to investigate the expression, biological functions, and clinical significance of miR-135b-5p in OSCC. Methods Bioinformatic analysis was used to predict targets of miR-135b-5p, and a dual-luciferase reporter assay verified the targeting relationship with TXNIP. In OSCC cell lines, cell proliferation and migration were assessed using CCK-8 and Transwell assays, respectively; oxidative damage and ferroptosis were evaluated by detecting intracellular levels of Fe2⁺, ROS, MDA, SOD, and related molecular markers. Additionally, peripheral blood samples from 117 OSCC patients were collected to analyze the correlation between miR-135b-5p and TXNIP expression and their relationship with clinicopathological parameters and patient prognosis. Results MiR-135b-5p was significantly upregulated in OSCC cells and patient blood, while TXNIP was downregulated. Overexpression of miR-135b-5p promoted OSCC cell proliferation and migration. Inhibition had the opposite effects. The dual-luciferase reporter assay confirmed that miR-135b-5p directly targets and negatively regulates TXNIP. Inhibition of miR-135b-5p or overexpression of TXNIP induced oxidative damage and promoted ferroptosis. Conversely, miR-135b-5p overexpression reduced H₂O₂-induced ferroptosis-an effect reversed by concurrent TXNIP overexpression. Clinical analysis revealed a significant negative correlation between miR-135b-5p and TXNIP expression. High miR-135b-5p expression or low TXNIP expression was significantly associated with lymph node metastasis and poorer overall survival. Multivariate Cox regression analysis indicated that both were independent prognostic factors for OSCC. Conclusion The miR-135b-5p/TXNIP axis critically regulates OSCC progression through ferroptosis and may serve as a prognostic biomarker and therapeutic target for OSCC.

Keywords: Ferroptosis; Oxidative damage; Squamous cell carcinoma of the oral mucosa; TXNIP; Tumor progression; miR-135b-5p.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing Interests: The authors have no relevant financial or non-financial interests to disclose. Consent to participate: Informed consent was obtained from all individual participants included in the study. Ethics approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of The Affiliated Hospital of Xuzhou Medical University.

References

    1. Capparuccia L, Tamagnone L. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin. J Cell Sci. 2009;122(Pt 11):1723–36. - DOI - PubMed
    1. Menditti D, Santagata M, Imola G, Staglianò S, Vitagliano R, Boschetti CE, et al. Personalized medicine in oral oncology: imaging methods and biological markers to support diagnosis of oral squamous cell carcinoma (OSCC): a narrative literature review. J Pers Med. 2023. https://doi.org/10.3390/jpm13091397 . - DOI - PubMed - PMC
    1. Moratin J, Zittel S, Ristow O, Hoffmann J, Freier K, Horn D. Reconstruction in early squamous cell carcinoma of the oral cavity-do free flaps improve oncological outcome? J Stomatol Oral Maxillofac Surg. 2025;126(4):102121. - DOI - PubMed
    1. Ling Z, Cheng B, Tao X. Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: challenges and opportunities. Int J Cancer. 2021;148(7):1548–61. - DOI - PubMed
    1. Panarese I, Aquino G, Ronchi A, Longo F, Montella M, Cozzolino I, et al. Oral and oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route. Expert Rev Anticancer Ther. 2019;19(2):105–19. - DOI - PubMed

LinkOut - more resources